Optimizing drug combinations to resurrect the potency of failed antibody therapy against emerging COVID-19 variants using IDentif.AI.
- DOI
- 10.3389/fdgth.2026.1744623
- Published
- 2026
- Container
- Frontiers in digital health
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fdgth.2026.1744623,
title = {Optimizing drug combinations to resurrect the potency of failed antibody therapy against emerging COVID-19 variants using IDentif.AI.},
author = {Wang P and You K and Chia ZW and Hooi L and Chong LM and Chye H and Moh A and Lee ZY and Lim E and Kok AZX and Chua S and Zhuang I and Chang E and Tan BH and Tan GGY and Vasoo S and Chan CEZ and Chow EK and Ho D},
year = {2026},
journal = {Frontiers in digital health},
doi = {10.3389/fdgth.2026.1744623},
url = {https://doi.org/10.3389/fdgth.2026.1744623}
}RIS
TY - JOUR TI - Optimizing drug combinations to resurrect the potency of failed antibody therapy against emerging COVID-19 variants using IDentif.AI. AU - Wang P AU - You K AU - Chia ZW AU - Hooi L AU - Chong LM AU - Chye H AU - Moh A AU - Lee ZY AU - Lim E AU - Kok AZX AU - Chua S AU - Zhuang I AU - Chang E AU - Tan BH AU - Tan GGY AU - Vasoo S AU - Chan CEZ AU - Chow EK AU - Ho D PY - 2026 JO - Frontiers in digital health DO - 10.3389/fdgth.2026.1744623 UR - https://doi.org/10.3389/fdgth.2026.1744623 ER -
APA
P, W., K, Y., ZW, C., L, H., LM, C., H, C., A, M., ZY, L., E, L., AZX, K., S, C., I, Z., E, C., BH, T., GGY, T., S, V., CEZ, C., EK, C., & D, H. (2026). Optimizing drug combinations to resurrect the potency of failed antibody therapy against emerging COVID-19 variants using IDentif.AI.. Frontiers in digital health. https://doi.org/10.3389/fdgth.2026.1744623
Source records
- pubmed · retrieved 2026-09-26T08:02:51.443Z